Advertisement
Canada markets closed
  • S&P/TSX

    21,708.44
    +52.39 (+0.24%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • DOW

    37,775.38
    +22.07 (+0.06%)
     
  • CAD/USD

    0.7249
    -0.0015 (-0.20%)
     
  • CRUDE OIL

    85.24
    +2.51 (+3.03%)
     
  • Bitcoin CAD

    84,322.35
    -784.25 (-0.92%)
     
  • CMC Crypto 200

    1,260.72
    +375.18 (+40.07%)
     
  • GOLD FUTURES

    2,422.00
    +24.00 (+1.00%)
     
  • RUSSELL 2000

    1,942.96
    -4.99 (-0.26%)
     
  • 10-Yr Bond

    4.6470
    +0.0620 (+1.35%)
     
  • NASDAQ futures

    17,306.75
    -240.50 (-1.37%)
     
  • VOLATILITY

    18.00
    -0.21 (-1.15%)
     
  • FTSE

    7,877.05
    +29.06 (+0.37%)
     
  • NIKKEI 225

    36,827.67
    -1,252.03 (-3.29%)
     
  • CAD/EUR

    0.6825
    +0.0004 (+0.06%)
     

Why Haemonetics Stock Fell 13% Today

Why Haemonetics Stock Fell 13% Today

Investors were not kind to Haemonetics (NYSE: HAE) on Thursday, trading the stock down by more than 13%. The sell-off occurred in the wake of the blood and plasma collection systems company's 2021 earnings release for the fiscal fourth quarter of 2021. The quarter saw Haemonetics earn $221 million in revenue, down 6% on a year-over-year basis.